7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... killed - rest LTBI ... Tuberculosis Diagnosis ... #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI ... killed - rest LTBI ... Tuberculosis Diagnosis ... #Diagnosis #Management ... #Treatment #ActiveTB
Pulmonary Infections in HIV-AIDS
Bacterial: 
 • No organism identified, Strep pneumoniae, H. influenzae, S.aureus, Streptococcus Grp
organism identified, Strep ... • CD4 < 200: CMV ... failure, COPD, Lung ... Fungal, AFB), TB ... HIVAIDS #workup #diagnosis
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... and molecular diagnostic ... Guidelines for dosing ... #IDSA #Prevention ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... end-organ disease ... best prevented by using ... #IDSA #Prevention ... #HIVAIDS #pharmacology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess - Diagnosis ... polymicrobial infection ... Aeruginosa - Strep ... Cryptococcus - Coccidioides ... westermani • Other: TB
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... are contacts of infectious ... antimicrobials #regimens #pharmacology ... #dosing #idsa # ... drugs #steps